D-0703-2017 Class III Terminated

Recalled by Teva Pharmaceuticals USA — North Wales, PA

Recall Details

Product Type
Drugs
Report Date
May 17, 2017
Initiation Date
March 28, 2017
Termination Date
October 24, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
49,089 bottles

Product Description

PrednisoLONE Oral Solution USP, 15 mg/5mL, alcohol content: 5%(v/v) 240 mL bottle, Rx Only, Manufactured in Canada By: CONTRACT PHARMACEUTICALS LIMITED CANADA, Ontario, Canada, L5N 6L6, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-6118-87

Reason for Recall

Failed Stability Specifications

Distribution Pattern

Nationwide

Code Information

Lot # 94358; Exp. 05/17 Lot # 94920A; Exp. 07/17 Lot # 97083A; Exp. 12/17